Buy Cellcept : Mycophenolate 500 mg Tablets 50’S Online

Description

Description:

Cellcept is a medication manufactured by Roche Holding AG. It is marketed under the brand name Cellcept. Each tablet of Cellcept contains 500 mg of Mycophenolate Mofetil. The tablets are available in packs containing 50 tablets.

Active Ingredient:

Mycophenolate Mofetil: Mycophenolate Mofetil is an immunosuppressive medication used to prevent organ rejection in patients who have received kidney, heart, or liver transplants. It belongs to a class of drugs known as immunosuppressants. Mycophenolate Mofetil works by inhibiting the proliferation of T-lymphocytes, a type of white blood cell involved in the immune response. By suppressing the immune system, Mycophenolate Mofetil helps prevent the rejection of transplanted organs.

Manufacturer:

Roche Holding AG: Cellcept is manufactured by Roche Holding AG, a multinational healthcare company known for its expertise in pharmaceuticals and diagnostics. Roche Holding AG is committed to improving patient outcomes through innovation and research in healthcare.

Indications:

Cellcept (Mycophenolate Mofetil) is indicated for the prophylaxis of organ rejection in patients receiving allogeneic kidney, heart, or liver transplants. It is used in combination with other immunosuppressive medications, such as corticosteroids and calcineurin inhibitors, to prevent rejection and improve transplant outcomes. Cellcept is typically initiated before transplantation and continued post-transplantation as part of a comprehensive immunosuppressive regimen.

Dosage and Administration:

The dosage of Cellcept (Mycophenolate Mofetil) may vary depending on factors such as the type of transplant, patient’s body weight, renal function, and concomitant immunosuppressive therapy. It is usually taken orally in tablet form, with the recommended dosage ranging from 1 to 1.5 grams twice daily for kidney transplant recipients and 1.5 grams twice daily for heart or liver transplant recipients. The tablets should be swallowed whole with a glass of water, preferably on an empty stomach or at least one hour before or two hours after meals.

Side Effects:

Common side effects associated with Cellcept (Mycophenolate Mofetil) may include:

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Insomnia
• Fatigue
• Increased susceptibility to infections

More serious side effects, although rare, may include bone marrow suppression, leukopenia, anemia, thrombocytopenia, gastrointestinal perforation, and increased risk of lymphoma or other malignancies. Patients should be monitored regularly for signs of adverse effects, and any unusual or severe symptoms should be reported to the healthcare provider promptly.

Precautions:

Before starting treatment with Cellcept (Mycophenolate Mofetil), patients should inform their healthcare provider about any underlying medical conditions, allergies, or medications they are currently taking. Mycophenolate Mofetil may interact with certain medications, so it is essential to discuss potential drug interactions with the healthcare provider. Pregnant or breastfeeding women should avoid using Cellcept, as it may cause harm to the fetus or infant. Patients should follow the prescribed dosage and regimen and attend regular follow-up appointments with their healthcare provider to monitor for potential adverse effects and ensure optimal transplant outcomes. Cellcept should be used under the supervision of a qualified healthcare provider experienced in the management of transplant patients.